ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Gene Therapy

Boston cell and gene therapy manufacturing center planned

by Ryan Cross
November 30, 2019 | APPEARED IN VOLUME 97, ISSUE 47

A high-profile team of academic, medical, and industry partners is forming a $50 million center for cell and gene therapy manufacturing in Boston. The approximately 2,800 m2 site is slated to open by the end of 2021 for academic, hospital, and start-up researchers. Harvard University, Massachusetts Institute of Technology, Fujifilm Diosynth Biotechnologies, GE Healthcare Life Sciences, Millipore Sigma, Alexandria Real Estate Equities, five major Boston hospitals, and the State of Massachusetts are contributing to the center.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment